Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis

British Journal of Haematology

Volumn 109, Issue 2, 2000, Pages 342-348

  Robbie, L A ^a   Dummer, S ^a   Booth, N A ^a   Adey, G D ^a   Bennett, B ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Mononuclear cells; PAI 2; Polymorphs; Septic shock; U PA

Indexed keywords

ANTIGEN; FIBRIN; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LEUKOCYTE; MONONUCLEAR CELL; MULTIPLE ORGAN FAILURE; PATHOGENESIS; PLASMINOGEN ACTIVATION; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEPSIS; SEPTIC SHOCK;

ANTIGENS; FIBRINOGEN; HUMANS; LEUKOCYTES; MULTIPLE ORGAN FAILURE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; SHOCK, SEPTIC; STATISTICS, NONPARAMETRIC; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034042450     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02057.x     Document Type: Article

References (26)

1. Bennett, B. & Ogston, D. (1996) Fibrinolytic bleeding disorders. In: Disorders of Haemostasis (ed. by O.D. Ratnoff & ( C.D Forbes), pp. 296-322. W.B. Saunders, Philadelphia.
2. 2-macroglobulin and C1-inhibitor: studies in patients with defibrination and a fibrinolylic state after electroshock or complicated labor. Blood, 75, 671-676.
3. Booth, N.A. (1994) The natural inhibitors of fibrinolysis. In: Haemostasis and Thrombosis, Vol. 3, 3rd edn (ed. by A.L. Bloom, C.D. Forbes, D.P. Thomas & E.G.D. Tuddenham), pp. 699-717. Churchill Livingstone, Edinburgh.
4. Booth, N.A., Anderson, J.A. & Bennett, B. (1985) Platelet release protein which inhibits plasminogen activators. Journal of Clinical Pathology, 38, 825-830.
5. Booth, N.A., Walker, E., Maugham, R. & Bennett, B. (1987a) Plasminogen activator in subjects after exercise and venous occlusion; t-PA complexes with C1 inhibitor and PAI-1. Blood, 69, 1600-1604.
6. Booth, N.A., MacGregor, I.R., Hunter, N.R. & Bennett, B. (1987b) Plasminogen activator inhibitor from human endothelial cells; purification and partial characterisation. European Journal of Biochemistry, 165, 595-600.
7. Booth, N.A., Simpson, A.J., Croll, A., Bennett, B. & MacGregor, I.R. (1988) Plasminogen activator inhibitor in plasma and platelets. British Journal of Haematology, 70, 327-333.
8. Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus, W.A., Schein, R.M. & Sibbald, W.J. (1992) The ACCP/SCCM Consensus Conference Committee: definition of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 101, 1644-1655.
9. Haj, M.A., Neilly, I.J., Robbie, L.A. & Adey, Bennett, B. (1995a) Influence of white blood cells on fibrinolytic response to sepsis: studies on septic patients with or without severe leucopenia. British Journal of Haematology, 90, 541-547.
10. Haj, M.A., Robbie, L.A., Adey, G.D. & Bennett, B. (1995b) Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients. Thrombosis and Haemostasis, 74, 1528-1532.
11. Jackson, M.R., Moore, N.R., Ritchie, H.R. & Booth, N.A. (1996) Enhanced cell-associated u-PA activity of endothelial cells in response to soluble factors released by blood monocytes. Blood Coagulation and Fibrinolysis, 7, 728.
12. Kruithof, E.K.O., Baker, M.S. & Bunn, C.L. (1995) Biological and clinical aspects of plasminogen activator type 2. Blood, 86, 4007-40024.
13. Levin, E.G. & Loskutoff, D.J. (1979) Comparative studies of the fibrinolytic activity of cultured vascular cells. Thrombosis Research, 15, 869-878.
14. MacGregor, I.R. & Booth, N.A. (1988) An enzyme-linked immunosorbent assay (ELISA) used to study cellular secretion of endothelial plasminogen activator inhibitor (PAI-1). Thrombosis and Haemostasis, 59, 68-72.
15. MacGregor, I.R., MacDonald, S., Dawes, J., Micklem, L.R. & James, K. (1987) A monoclonal antibody enzyme linked immunosorbent assay (ELISA) directed toward a fibrin binding region of tissuetype plasminogen activator. Fibrinolysis, 1, 247-252.
16. Mackie, M., Booth, N.A. & Bennett, B. (1981) Comparative studies on human activators of plasminogen. British Journal of Haematology, 47, 77-90.
17. McWilliam, N.A., Robbie, L.A., Barelle, C.J., Adey, G.D., Prasad, S., Bennett, B. & Booth, N.A. (1996) Evidence for an active fibrinolytic system in normal human bone marrow. British Journal of Haematology, 93, 170-176.
18. Philippe, J., Offner, F., Declerck, P.J., Leroux-Roels, G., Vogelaers, D., Baele, G. & Collen, D. (1991) Fibrinolysis and coagulation in patients with infectious disease and sepsis. Thrombosis and Haemostasis, 65, 291-299.
19. Philippe, J., Doojewaard, G., Offner, F., Turion, P., Baele, G. & Leroux-Roels, G. (1992) Granulocyte elastase, tumour necrosis factor alpha and urokinase levels as prognostic markers in severe infection. Thrombosis and Haemostasis, 68, 19-23.
20. Pintucci, G., Iacoviello, L., Amore, C., Evangelista, V., Cerletti, C. & Donati, D.M. (1992) Cathepsin G, a polymorphonuclear cell protease, affects the fibrinolytic system by releasing PAI-1 from endothelial cells and platelets. Annals of the New York Academy of Science, 667, 286-288.
21. Pralong, G., Calandra, T., Glauser, M.P., Schellekens, J., Verhoef, J., Bachmann, F. & Kruithof, E.K.O. (1989) Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thrombosis and Haemostasis, 61, 459-469.
22. Ritchie, H., Jamieson, A. & Booth, N.A. (1995) Thrombin modulates synthesis of plasminogen activator inhibitor 2 by human peripheral blood monocytes. Blood, 86, 3428-3435.
23. Robbie, L.A., Bennett, B., Croll, A.M., Brown, P.A. & Booth, N.A. (1996) Proteins of the fibrinolytic system in human thrombi. Thrombosis and Haemostasis, 75, 127-133.
24. Robbie, L.A., Young, S.P., Bennett, B. & Booth, N.A. (1997) Thrombi formed in a Chandler loop mimic human arterial thrombi in structure and PAI-1 content and distribution. Thrombosis and Haemostasis, 77, 510-515.
25. Suffredini, A.F., Harpel, P.C. & Parrillo, J.E. (1989) Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. New England Journal of Medicine, 320, 1165-1172.
26. Van Deventer, S.J.H., Buller, H.R., Ten Cate, J.W., Aarden, L.A., Hack, C.E. & Sturk, A. (1990) Experimental endotoxemia in humans; analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood, 76, 2520-2526.